These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4056535)

  • 1. [Enhancement of irradiation effect in carcinoma of the uterine cervix with the administration of protein-bound polysaccharide kureha (PS-K)].
    Kazuta M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1908-14. PubMed ID: 4056535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytological and histological effects of regional hyperthermia and radiation in cancer of the uterine cervix].
    Hasegawa K; Kinugasa M; Nishino R; Kimura A; Yukimura N; Ohtsu F; Takeuchi K
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1526-38. PubMed ID: 2809379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancing effect of irradiation on carcinoma of the uterine cervix by administering the protein-bound polysaccharide kureha (PSK)--quantitative nuclear DNA analysis following irradiation].
    Hayashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):179-86. PubMed ID: 3361173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of PS-K on long-term survival of uterine cervical cancer patients treated with radiation].
    Okazaki A; Mitsuhashi N; Yamakawa M; Nozaki M; Takeuchi M; Niibe H
    Gan No Rinsho; 1986 Feb; 32(2):181-5. PubMed ID: 3959339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
    Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
    Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histological study on immune reaction of advanced uterine cervical carcinoma with regard to the effect of a low-dose irradiation and PS-K.
    Tsukahara Y; Shiozawa I; Sakai Y; Ishii J; Iwai S; Fukuta T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):279-84. PubMed ID: 7234338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant immunotherapy for carcinoma of uterine cervix with PSK].
    Shiraki S; Mori H; Ito A; Kadomoto N; Yamagiwa S; Yamada Y; Noda K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1031-9. PubMed ID: 6985193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
    Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of uterine cervical carcinoma showing an interesting clinical course with PS-K after radiotherapy].
    Okazaki A; Mitsuhashi N; Yamakawa M; Nozaki M; Takeuchi M; Niibe H
    Rinsho Hoshasen; 1986 May; 31(5):659-62. PubMed ID: 3747223
    [No Abstract]   [Full Text] [Related]  

  • 10. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
    Marnitz S; Köhler C; Füller J; Hinkelbein W; Schneider A
    Strahlenther Onkol; 2006 Jan; 182(1):45-51. PubMed ID: 16404520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
    Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of locally advanced cervical carcinoma.
    Keys H; Gibbons SK
    J Natl Cancer Inst Monogr; 1996; (21):89-92. PubMed ID: 9023835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified irradiation dosimetry in carcinoma of the cervix (external irradiation and one radium insertion).
    Allen WE; Reddi RP
    J Natl Med Assoc; 1980 Apr; 72(4):361-70. PubMed ID: 7365825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients].
    Chauvergne J; Lhommé C; Rohart J; Héron JF; Ayme Y; Goupil A; Fargeot P; David M
    Bull Cancer; 1993 Dec; 80(12):1069-79. PubMed ID: 8081045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.